In photocatalysis, the resulted heat by the relaxation of most of incident light no longer acts as the industrially favorite driving force back to the target photo-reaction due to more or less the negative relation between photocatalytic efficiency and temperature. Here, we reported a visible light-sensitized protocol that completely reversed the negatively temperature-dependent efficiency in photo-driven CO methanation with saturated water vapor. Uniform Pt/N-TiO/PDI self-assembly material decisively injects the excited electron of PDI sensitizer into N-TiO forming Ti-H hydride which is crucially temperature-dependent nucleophilic species to dominate CO methanation, rather than conventionally separated and trapped electrons on the conductor band. Meanwhile, the ternary composite lifts itself temperature from room temperature to 305.2 °C within 400 s only by the failure excitation upon simulated sunlight of 2.5 W/cm, and smoothly achieves CO methanation with a record number of 4.98 mmol g h rate, compared to less than 0.02 mol g h at classic Pt/N-TiO/UV photocatalysis without PDI sensitization. This approach can reuse ~53.9 % of the relaxed heat energy from the incident light thereby allow high-intensity incident light as strong as possible within a flowing photo-reactor, opening the most likely gateways to industrialization.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/chem.202402102 | DOI Listing |
Arch Dermatol Res
January 2025
Department of Physiotherapy, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, 210042, China.
Background: Previous studies have proven that 308-nm light-emitting diode(308-nm LED)and 308-nm excimer lamp(308-nm MEL) are effective in treating vitiligo, but there is a lack of comparison of their efficacy for facial lesions.
Objective: To evaluate and contrast the treatment success rates of 308-nm LED versus 308-nm excimer lamp in managing facial lesions among patients suffering from stable non-segmental vitiligo.
Methods: The enrolled 119 patients with 145 lesions were randomly assigned to receive 308-nm LED or 308-nm MEL for two months.
Alzheimers Dement
December 2024
Weill Cornell Medicine, New York, NY, USA; St Vincent's Hospital, Melbourne, VIC, Australia.
Background: Postoperative delirium (POD) is a serious complication of surgery associated with prolonged hospitalisation, long-term cognitive decline, dementia and mortality. There is increasing evidence that electroencephalography (EEG) monitoring may reduce the incidence of POD, however, the best method for achieving this is unclear.
Method: This presentation will present the results of a multicentre randomised clinical trial of 515 at-risk patients undergoing major surgery from 8 centres in 3 countries who were assessed for POD for 5 days postoperatively.
Alzheimers Dement
December 2024
Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Background: Brain age (BA) prediction models have emerged as valuable tools for understanding individual differences in trajectories of brain aging. These models aim to estimate overall brain health by predicting BA based on structural MRI data. To enhance the specificity of existing BA models, we introduce a deep learning-based BA prediction model.
View Article and Find Full Text PDFBackground: By age 40 years, adults with Down syndrome (DS) develop Alzheimer's disease (AD) pathology and progress to dementia in their 60s. Despite minimal systemic vascular risk factors, individuals with DS have MRI evidence of cerebrovascular injury that progresses with AD severity, suggesting an intrinsic vascular component to DS-AD that may interact with neuroinflammatory processes to promote tau pathology and cognitive decline. In the current study we examined whether cerebrovascular disease (CVD) burden and inflammation/astrocytosis independently and interactively were associated with incident diagnosis among adults with DS.
View Article and Find Full Text PDFBackground: Recent research reveals that Alzheimer's Disease blood-based biomarkers (BBB) are influenced by demographics as well as kidney function and comorbidities. Data on differences in BBBs by race and ethnicity are sparse. We examined whether racial/ethnic differences in BBBs persist after controlling for kidney function and comorbidities.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!